United States Physicians' Knowledge, Attitudes, and Practices Regarding Meningococcal Vaccination for Healthy Adolescents and Young Adults
Open Access
- 13 February 2024
- journal article
- research article
- Published by Elsevier in Journal of Adolescent Health
- Vol. 74 (6) , 1131-1138
Abstract
No abstract availableKeywords
Funding Information
- GlaxoSmithKline (VEO-000273)
- GlaxoSmithKline (GPP 2022)
This publication has 11 references indexed in Scilit:
- Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey–Teen, United States, 2022MMWR. Morbidity and Mortality Weekly Report, 2023
- A Real-world Claims Data Analysis of Meningococcal Serogroup B Vaccine Series Completion and Potential Missed Opportunities in the United StatesThe Pediatric Infectious Disease Journal, 2022
- Long-Term Mortality and State Financial Support in Invasive Meningococcal Disease—Real-World Data Analysis Using the French National Claims Database (SNIIRAM)Infectious Diseases and Therapy, 2021
- Practice-, provider- and patient-level facilitators of and barriers to HPV vaccine promotion and uptake in Georgia: a qualitative study of healthcare providers’ perspectivesHealth Education Research, 2020
- Disparities in healthcare providers’ interpretations and implementations of ACIP’s meningococcal vaccine recommendationsHuman Vaccines & Immunotherapeutics, 2019
- Adoption of Serogroup B Meningococcal Vaccine RecommendationsPediatrics, 2018
- Current Epidemiology and Trends in Meningococcal Disease—United States, 1996–2015Clinical Infectious Diseases, 2017
- Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015MMWR. Morbidity and Mortality Weekly Report, 2015
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) StatementEpidemiology, 2007
- Time Allocation in Primary Care Office VisitsHealth Services Research, 2007